DUNG TRAN: Open Payments
NPI 1386644342 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 58 payments from 20 companies in 2025. Trend: 2023 $1,231 · 2024 $1,133 · 2025 $1,156
Food & beverage: $1,156
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $241 |
| AstraZeneca Pharmaceuticals LP | 5 | $200 |
| Ardelyx, Inc. | 5 | $133 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| PFIZER INC. | 4 | $76 |
| Novo Nordisk Inc | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Lilly USA, LLC | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $42 |
Products named: BREZTRI, IBSRELA, QULIPTA, TRELEGY ELLIPTA, VRAYLAR, ELIQUIS, FANAPT, UBRELVY.
Industry payments across LA — which companies pay providers there.
